化抗凝剂降低了血中多克西环素的测量值:对多克西 PEP 监测的影响
Michele B Daly1, Micah Spandau2, Tiancheng E Edwards1
1Laboratory Branch, Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA , USA.
Expert review of clinical pharmacology
|February 17, 2026
概括
像酸盐和EDTA这样的化抗凝剂显著降低了多西环林的血度. 为了准确的药物测量,使用非化抗凝剂或调整化剂.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床化学 临床化学
背景情况:
- 对于与性传播感染高风险男性发生性关系的男性,建议对多西环林进行暴露后预防.
- 准确的多西环林测量对于评估这种预防策略的坚持和有效性至关重要.
研究的目的:
- 为了研究不同抗凝剂对血多克西环林度的影响.
- 确定最佳的血液采集方法,以在临床试验中准确量化多西环林.
主要方法:
- 参与者接受了200毫克的多西环素,血液收集在酸盐或肝素管中.
- 活体实验比较了血中多克西环素水平与药物加注,收集在酸盐/氨酸或EDTA/氨酸.
- 血中多西环素的量化方法是使用液体染色学-并联质谱法.
主要成果:
- 血中多西环素AUC在酸盐血中比肝素血后剂量低3倍.
- 活体研究显示,在酸盐和EDTA血液中的多西环林度显著降低,而在肝素血液中则显著降低 (p < 0.0002).
结论:
- 化抗凝剂 (酸盐,EDTA) 显著降低血中多克西环素度,可能是通过破坏药物金属离子复合体和增加红细胞分裂.
- 药理学研究应优先考虑非化抗凝剂,或在使用化剂进行多西环林分析时应用校正因子.
关键词:
在多西环素暴露后的预防 (doxy PEP)抗凝固剂是一种抗凝固剂.液态染色学 质谱学 质谱学药物动力学 药物动力学性传播感染性传播感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性感染性相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K
Therapeutic Drug Monitoring: Affecting Factors
258
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
258
Pharmacokinetics: Drug–Drug Interactions
497
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
497
Therapeutic Drug Monitoring: Drug Analysis Methods
223
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
223
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.0K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K
Therapeutic Drug Monitoring: Overview and Classification
388
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
388


